|
|
China Biopharma Searches for Mission, Money
publication date: Dec 3, 2007
China Biopharma announced recently that it was getting out of the vaccine business, because the vaccine market in China has too many players, making the business too competitive and causing the margins to thin to unacceptable levels. Instead, the company will seek specialty pharmaceutical products as a long-term project. In the short term, it will build up its distribution business and increase its ownership in its subsidiary companies. Meanwhile, the financial situation of China Biopharma remains dire. More details...
Stock Symbol: (OTCBB: CBPC)
|
ChinaBio® Events
April 14, 2010 Guangzhou, China Suzhou, China June 23-24, 2010
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|